Literature DB >> 20800508

Hemochromatosis genotypes and risk of iron overload--a meta-analysis.

Adriana Maria Neghina1, Andrei Anghel.   

Abstract

PURPOSE: The incomplete phenotypic penetrance of high iron Fe genotypes in relation to hemochromatosis poses a practical problem in the interpretation of the genotyping results by clinicians. We carried out meta-analyses of the associations between hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, C282Y/wild-type, H63D/H63D, H63D/wild-type, versus wild-type/wild-type and iron overload, both provisional (elevated serum iron markers) and documented (elevated serum iron markers associated with evidence of iron excess based on liver biopsy and/or quantitative phlebotomy).
METHODS: After reviewing 3572 article titles and evaluating 92 articles in detail, odds ratios were pooled from 43 study populations (9986 cases and 25,492 controls) using a random-effects model.
RESULTS: Homozygosity for either variant or compound heterozygosity was associated with both provisional and documented iron overload. Single heterozygosity conferred no risk for elevated hepatic iron index and/or mobilizable iron by quantitative phlebotomy. In patients with clinical hereditary hemochromatosis, no evidence of provisional and documented iron overload with transferrin saturation (TS) values greater than 55% was evidenced for C282Y and H63D single heterozygotes whereas documented iron overload including TS of 45% to 50% was weakly associated with C282Y/wild-type genotype; H63D/H63D genotype was not associated with documented iron overload in patients with TS values of 45% to 50%.
CONCLUSIONS: The results, mainly from case-control studies, cannot necessarily be extrapolated to the general population.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800508     DOI: 10.1016/j.annepidem.2010.05.013

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  14 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.

Authors:  Yan-Yan Xu; Yu-Han Tang; Xiao-Ping Guo; Jing Wang; Ping Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

3.  Should we screen for hereditary hemochromatosis in healthy Lebanese: a pilot study.

Authors:  Rami A R Mahfouz; Doja S Sarieddine; Khalil M Charafeddine; Rabab N Abdul Khalik; Najwa K Cortas; Rose T Daher
Journal:  Mol Biol Rep       Date:  2011-05-07       Impact factor: 2.316

4.  HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.

Authors:  Paul C Adams; Christine E McLaren; Mark Speechley; Gordon D McLaren; James C Barton; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

5.  Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.

Authors:  Steven E Lipshultz; Stuart R Lipsitz; Jeffery L Kutok; Tracie L Miller; Steven D Colan; Donna S Neuberg; Kristen E Stevenson; Mark D Fleming; Stephen E Sallan; Vivian I Franco; Jacqueline M Henkel; Barbara L Asselin; Uma H Athale; Luis A Clavell; Bruno Michon; Caroline Laverdiere; Eric Larsen; Kara M Kelly; Lewis B Silverman
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

6.  Iron overload is rare in patients homozygous for the H63D mutation.

Authors:  Melissa Kelley; Nikhil Joshi; Yagang Xie; Mark Borgaonkar
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

7.  Anti-obesity and pro-diabetic effects of hemochromatosis.

Authors:  Mousa Al Abbas; Deveraprabu Abraham; James P Kushner; Donald A McClain
Journal:  Obesity (Silver Spring)       Date:  2014-07-14       Impact factor: 5.002

8.  Genetic variant coding for iron regulatory protein HFE contributes to hypertension, the TAMRISK study.

Authors:  Kirsi M Määttä; Seppo T Nikkari; Tarja A Kunnas
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

10.  High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus.

Authors:  Julie Nyholm Kyvsgaard; Anne Julie Overgaard; Steffen Ullitz Thorsen; Thomas Hesselhøj Hansen; Christian Bressen Pipper; Henrik Bindesbøl Mortensen; Flemming Pociot; Jannet Svensson
Journal:  Nutrients       Date:  2017-11-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.